Michael Bardo earned his PhD at Iowa State University in 1980, specializing in animal learning and psychopharmacology, and he received postdoctoral training in neuropharmacology in the Department of Pharmacology at the University of Iowa. In 1982, he assumed a faculty position in the Department of Psychology at the University of Kentucky, where he now holds the rank of Full Professor. Bardo has over 100 publications and he currently serves as Director of CDART. His current research interests are focused on understanding the role of environmental stimuli in controlling drug self-administration in laboratory animals, and the long-term goal is to translate this basic science into the development of improved prevention interventions.
Richard Clayton is a sociologist by training and is the Good Samaritan Foundation Chair in Health Behavior in the Kentucky School of Public Health. He is also the Chair of the Robert Wood Johnson Foundation Tobacco Etiology Research Network. TERN consists of 14 senior scientists from 13 different institutions and as many disciplines, and 11 TERN Faculty Scholars (assistant or associate professor scientists) from 8 different institutions. He is serving as Senior Science Advisor in CDART. Clayton is focused on inter-individual differences in intra-individual changes in trajectories of tobacco use in nested contexts.
Linda Dwoskin is a neuropharmacologist and the US Surgical-Pfizer Endowed Professor in Pharmaceutical Sciences in the College of Pharmacy. She earned her PhD from the Department of Pharmacology at the University of Minnesota in 1983. In 1988, Dwoskin was appointed as an Assistant Professor in the College of Pharmacy and rose through the ranks to become the first woman basic-scientist Full Professor in the College. Dwoskin has over 100 publications and 15 patent and patent applications. Dwoskin serves on the Executive Committee of CDART and as a co-investigator on Project 1. Her research interests are focused on the development of novel treatments for drug abuse and on understanding the role of genetics and environmental factors underlying individual responsiveness to drugs of abuse and an individual's potential for abuse liability
Thomas Kelly earned his PhD at the University of Minnesota in 1983, specializing in Experimental Psychology and Behavioral Pharmacology. He received postdoctoral training in Human Behavioral Pharmacology at the Veterans Administration Medical Center and in the Department of Psychiatry at the Louisiana State University School of Medicine in Shreveport, Louisiana. In 1992, he assumed a faculty position in the Department of Behavioral Science at the University of Kentucky, where he now holds the rank of Full Professor. Kelly currently serves as the Scientific Director of CDART and is Principal Investigator for Project 2. His current research interests are focused on understanding individual differences in vulnerability to drug abuse and environmental influences on drug abuse liability.
Donald Lynam Donald Lynam earned his PhD at the University of Wisconsin-Madison in clinical psychology in 1995. He is currently a Professor in the Department of Psychology at Purdue University. He has over 50 publications and was the 2002 recipient of the American Psychological Association Distinguished Scientific Award for Early Career Contribution to Psychology. He is currently a member of the CDART executive committee and Principal Investigator for Project 3. His current research interests are focused on understanding the role of individual differences in personality on the development and maintenance of deviant behavior (i.e., antisocial behavior, substance abuse, and risky sexual behavior).
Richard Milich earned his Ph.D. in clinical psychology from Washington University in 1976, and did postdoctoral work in child psychopathology at the University of Iowa. In 1985 he joined the faculty in the Department of Psychology at the University of Kentucky, where he is now Professor and Associate Chair. Milich is Administrative Director of CDART. His research interests involve children's behavior problems, especially attention deficit hyperactivity disorder and conduct disorder. He has been involved in a long-term follow-up study examining how these early behavior problems may put these children at risk for later substance use problems.
Nancy Grant Harrington earned her Ph.D. in communication from Univeristy of Kentucky in 1992. Harrington joined the Department of Communication in January 1993 and joined the Center the following October as the Deputy Scientific Director. She is currently Chair in the department of Communication. Her research interests focuses primarily on persuasive message design in a health behavior change context
Donald Lynam earned his PhD at the University of Wisconsin-Madison in clinical psychology in 1995. He is currently an Associate Professor in the Department of Psychology at the University of Kentucky. He has over 50 publications and was the 2002 recipient of the American Psychological Association Distinguished Scientific Award for Early Career Contribution to Psychology. He is currently a member of the CDART executive committee and Principal Investigator for Project 3. His current research interests are focused on understanding the role of individual differences in personality on the development and maintenance of deviant behavior (i.e., antisocial behavior, substance abuse, and risky sexual behavior).
Robert Lorch earned his PhD from the University of Massachusetts, Amherst, in 1980. Upon completing his degree, he assumed a faculty position at the University of Kentucky, where he now holds the rank of Full Professor. He has taught courses in statistics and cognitive psychology throughout his tenure at the University. His research interests focus on reading comprehension and the use of information acquired from text.
Thomas Garrity received his Ph.D. in sociology in 1971 from Duke University with a specialization in medical sociology. He was appointed Instructor in the Department of Behavioral Science, College of Medicine at the University of Kentucky in 1970. He was promoted to the rank of Professor in 1981 and served as Chair of Behavioral Science from 1988 to 2000. In relation to CDART, Garrity is serving as program director of the NIDA institutional training program. Over the years he has conducted research on predictors of recovery after myocardial infarction, behavioral risk factors in coronary heart disease, including behavioral stress and its moderators. He is currently involved in studies of drug abuse, especially determinants of health status in users both incarcerated and living in the community. Stress and coping dispositions are of special interest for understanding intensification of and relapse to drug abuse.
Linda Dwoskin is a neuropharmacologist and the US Surgical-Pfizer Endowed Professor in Pharmaceutical Sciences in the College of Pharmacy. She earned her PhD from the Department of Pharmacology at the University of Minnesota in 1983. In 1988, Dwoskin was appointed as an Assistant Professor in the College of Pharmacy and rose through the ranks to become the first woman basic-scientist Full Professor in the College. Dwoskin has over 100 publications and 15 patent and patent applications. Dwoskin serves on the Executive Committee of CDART and as a co-investigator on Project 1. Her research interests are focused on the development of novel treatments for drug abuse and on understanding the role of genetics and environmental factors underlying individual responsiveness to drugs of abuse and an individual's potential for abuse liability.
Louis Hersh is a biochemist and the Chair of Department of Molecular and Cellular Biology in the College of Medicine at the University of Kentucky. He received his Ph.D. from Brandeis University. His research interests include: the cholinergic gene locus which is unique in that it is comprised of two genes; the gene for choline acetyltransferase and the gene for the vesicular acetylcholine transporter; and the regulation of neuropeptide hormone action by peptidases.
Leslie Crofford earned her MD from the University of Tennessee Center for Health Sciences College of Medicine in Mephis Tennessee. Currently she is a Professor of Internal Medicine, Chief, Division of Rheumatology, Gloria W. Singletary Chair, and Director, Center for the Advancement of Women’s Health at the University of Kentucky. Her research interests are in Rheumatoid arthritis (inflammatory mediators, prostaglandins and cyclooxygenase); fibromyalgia epidemiology, genetics, pathophysiology and treatment; epidemiology of autoimmune disease; intense immunosuppression and stem cell transplant in scleroderma; treatment of polymyositis/dermatomyositis.
Nancy Grant Harrington earned her Ph.D. in 1992 from the University of Kentucky and is an Associate Professor and Chairperson of the Department of Communication in the College of Communications and Information Studies, University of Kentucky. She also holds an academic appointment in the School of Public Health and is a faculty associate of the Multidisciplinary Center on Drug and Alcohol Abuse. She has been involved as a principal investigator, co-investigator or principal evaluator with several NIH-funded studies. She teaches undergraduate and graduate courses in interpersonal communication, health communication and communication theory. Her research focuses on persuasive message design in a health behavior change context.
Carl Leukefeld is Professor of Behavioral Science, Psychiatry, Oral Health Science and Social Work; and Chair of the Department of Behavioral Science and Director of the Center on Drug and Alcohol Research, with a graduate appointment in Sociology. He came to the University of Kentucky in 1990 to establish the Center on Drug and Alcohol Research from the National Institute on Drug Abuse where he filled administrative and research positions. Leukefeld has published over 150 articles, chapters, books and monographs. He currently serves on the NIH Community-Level Health Promotion Study Section and has served on the NIH/NIDA Health Services Initial Review Group and as a reviewer and consulting editor for seven journals. His research interests include treatment interventions, outcomes, HIV prevention, criminal justice sanctions, health services, and rural populations.
Philip Palmgreen is Professor of Communication at the University of Kentucky. He is widely known for his work on media campaigns and prevention of risky behavior, especially drug use. He has served as principal or co-principal investigator on a series of projects (totaling over $10 million in funding) supported by the National Institute on Drug Abuse and the National Institute of Mental Health investigating the design and targeting of televised public service announcements for populations at-risk for drug abuse or HIV infection. He served for four years as a primary scientific advisor to the Office of National Drug Control Policy's $1 billion National Youth Anti-Drug Media Campaign. He has authored over 50 research articles and book chapters, edited two books, and presented over 50 scholarly papers.
